These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Deltamycins, new macrolide antibiotics. I. Producing organism and fermentation. Shimauchi Y; Okamura K; Koki A; Hasegawa M; Date M; Fukagawa Y; Kouno K; Ishikura T J Antibiot (Tokyo); 1978 Apr; 31(4):261-9. PubMed ID: 659323 [TBL] [Abstract][Full Text] [Related]
5. Chemical modification of deltamycins. I. 4''-O-acyl analogs of deltamycins. Shimauchi Y; Hori K; Sakamoto M; Mutoh Y; Fukagawa Y; Hori S; Ishikura T; Lein J J Antibiot (Tokyo); 1980 Mar; 33(3):284-92. PubMed ID: 7380741 [TBL] [Abstract][Full Text] [Related]
6. Modifications of a macrolide antibiotic midecamycin (SF-837). I. Synthesis and structure of 9,3''-diacetylmidecamycin. Omoto S; Iwamatsu K; Inouye S; Niida T J Antibiot (Tokyo); 1976 May; 29(5):536-48. PubMed ID: 956042 [TBL] [Abstract][Full Text] [Related]
7. Macrolide antibiotics M-4365 produced by Micromonospora. II. Chemical structures. Kinumaki A; Harada KI; Suzuki T; Suzuki M; Okuda T J Antibiot (Tokyo); 1977 Jun; 30(6):450-4. PubMed ID: 885805 [TBL] [Abstract][Full Text] [Related]
8. Microbial transformation of antibiotics II. Additional transformation products of maridomycin III. Shibata M; Uyeda M; Mori S J Antibiot (Tokyo); 1976 Aug; 29(8):824-8. PubMed ID: 993121 [TBL] [Abstract][Full Text] [Related]
9. Physico-chemical properties of new acyl derivatives of tylosin produced by microbial transformation. Okamoto R; Fukumoto T; Nomura H; Kiyoshima K; Nakamura K; Takamatsu A; Naganawa H; Takeuchi T; Umezawa H J Antibiot (Tokyo); 1980 Nov; 33(11):1300-8. PubMed ID: 7251471 [TBL] [Abstract][Full Text] [Related]
10. Deepoxidation of 16-membered epoxyenone macrolide antibiotics. III. In vitro and in vivo evaluation of deepoxidation products of carbomycin A, deltamycin A1, 4"-phenylacetyldeltamycin, angolamycin and rosamicin. Sakamoto M; Mutoh Y; Fukagawa Y; Ishikura T; Lein J J Antibiot (Tokyo); 1984 Feb; 37(2):130-5. PubMed ID: 6706849 [TBL] [Abstract][Full Text] [Related]
11. Studies on juvenimicin, a new antibiotic. II. Isolation, chemical characterization and structures. Kishi T; Harada S; Yamana H; Miyake A J Antibiot (Tokyo); 1976 Nov; 29(11):1171-81. PubMed ID: 993104 [TBL] [Abstract][Full Text] [Related]
12. Studies on the biosynthesis of 16-membered macrolide antibiotics using carbon-13 nuclear magnetic resonance spectroscopy. Omura S; Takeshima H; Nakagawa A; Miyazawa J; Piriou F; Lukacs G Biochemistry; 1977 Jun; 16(13):2860-6. PubMed ID: 18162 [TBL] [Abstract][Full Text] [Related]
13. Hybrid biosynthesis of derivatives of protylonolide and M-4365 by macrolide-producing microorganisms. Sadakane N; Tanaka Y; Omura S J Antibiot (Tokyo); 1982 Jun; 35(6):680-7. PubMed ID: 7118724 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of the ribosomal peptidyl transferase reaction by the mycarose moiety of the antibiotics carbomycin, spiramycin and tylosin. Poulsen SM; Kofoed C; Vester B J Mol Biol; 2000 Dec; 304(3):471-81. PubMed ID: 11090288 [TBL] [Abstract][Full Text] [Related]
15. Analytical studies of maridomycin. I. High-performance liquid chromatography of marido-mycins and some other macrolide antibiotics. Kondo K J Chromatogr; 1979 Feb; 169():329-36. PubMed ID: 536423 [TBL] [Abstract][Full Text] [Related]
16. Maridomycin, a new macrolide antibiotic. XI. The structures of maridomycin components. Muroi M; Izawa M; Kishi T Chem Pharm Bull (Tokyo); 1976 Mar; 24(3):463-78. PubMed ID: 1021252 [No Abstract] [Full Text] [Related]